Advancements in HLC differentiation and modeling have also proven useful in studying infectious diseases such as malaria and hepatitis B. An iPSC-based model of malaria was improved by using a small molecule to induce CYP expression such that antimalarial drugs requiring CYP bioactivation could be effectively tested [48]. This evidence concerns the gene PPIG and hepatitis B virus infection.